Ilonov

Private

StrasbourgHealthcare & Life Scienceshttps://www.ilonov-diabetes.com/

Last Round

Accelerator

Mar 13, 2025

Total Funding Raised

$600,000

Company Overview

Ilonov is a biotechnology company that develops first-in-class biotherapies for the treatment of diabetes and metabolic diseases by leveraging the potential of the muscle secretome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologybiotherapeuticdiabetes treatmentpancreatic beta-cellmetabolic diseaseislet transplantmuscle secretomedrug discoverycell therapypreclinical researchbiotech startupmyokine therapyprecision medicineregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ilonov Comps

Public and private peers based on sector, stage, and business model.

Ilonov comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ilonov Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Mar 13, 2025
Grant	Jan 22, 2023
Accelerator	Jun 1, 2022
Grant	Sep 1, 2021
Pre Seed	Jan 1, 2021

View all Funding Rounds

Ilonov Investors

Notable investors and investment history

Ilonov investors
Investor	Rounds
BaseLaunch	Accelerator
Région Grand Est	Grant
Bpifrance	Pre Seed, Grant

View all Investors

Ilonov Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ilonov Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ilonov's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg

Employee Range7

Year Founded2020

Last FundingMar 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.